105 related articles for article (PubMed ID: 20727916)
1. The C-terminal flanking peptide (CTFP) of progastrin inhibits apoptosis via a PI3-kinase-dependent pathway.
Patel O; Marshall KM; Bramante G; Baldwin GS; Shulkes A
Regul Pept; 2010 Dec; 165(2-3):224-31. PubMed ID: 20727916
[TBL] [Abstract][Full Text] [Related]
2. The C-terminal flanking peptide of progastrin induces gastric cell apoptosis and stimulates colonic cell division in vivo.
Marshall KM; Patel O; Bramante G; Laval M; Yim M; Baldwin GS; Shulkes A
Peptides; 2013 Aug; 46():83-93. PubMed ID: 23742999
[TBL] [Abstract][Full Text] [Related]
3. Production, secretion, and biological activity of the C-terminal flanking peptide of human progastrin.
Smith KA; Patel O; Lachal S; Jennings I; Kemp B; Burgess J; Baldwin GS; Shulkes A
Gastroenterology; 2006 Nov; 131(5):1463-74. PubMed ID: 17101322
[TBL] [Abstract][Full Text] [Related]
4. Identity and regulation of stored and secreted progastrin-derived peptides in sheep.
Paterson AC; Lockhart SM; Baker J; Neumann G; Baldwin GS; Shulkes A
Endocrinology; 2004 Nov; 145(11):5129-40. PubMed ID: 15308616
[TBL] [Abstract][Full Text] [Related]
5. Glycine-extended gastrin inhibits apoptosis in colon cancer cells via separate activation of Akt and JNK pathways.
Beales IL; Ogunwobi O
Mol Cell Endocrinol; 2006 Mar; 247(1-2):140-9. PubMed ID: 16442704
[TBL] [Abstract][Full Text] [Related]
6. COOH-terminal 26-amino acid residues of progastrin are sufficient for stimulation of mitosis in murine colonic epithelium in vivo.
Ottewell PD; Varro A; Dockray GJ; Kirton CM; Watson AJ; Wang TC; Dimaline R; Pritchard DM
Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G541-9. PubMed ID: 15486344
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of recombinant progastrin in sheep.
Paterson AC; Baldwin GS; Shulkes A
Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E449-56. PubMed ID: 12169437
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45.
Osaki M; Kase S; Adachi K; Takeda A; Hashimoto K; Ito H
J Cancer Res Clin Oncol; 2004 Jan; 130(1):8-14. PubMed ID: 14605879
[TBL] [Abstract][Full Text] [Related]
9. Concomitant inactivation of the epidermal growth factor receptor, phosphatidylinositol 3-kinase/Akt and Janus tyrosine kinase 2/signal transducer and activator of transcription 3 signalling pathways in cardiotoxin III-treated A549 cells.
Su JC; Lin KL; Chien CM; Chuang PW; Chang LS; Lin SR
Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):833-40. PubMed ID: 20456425
[TBL] [Abstract][Full Text] [Related]
10. Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells.
Stepan VM; Sawada M; Todisco A; Dickinson CJ
Mol Med; 1999 Mar; 5(3):147-59. PubMed ID: 10404512
[TBL] [Abstract][Full Text] [Related]
11. Naming progastrin-derived peptides.
Rehfeld JF; Bundgaard JR; Goetze JP; Friis-Hansen L; Hilsted L; Johnsen AH
Regul Pept; 2004 Aug; 120(1-3):177-83. PubMed ID: 15177936
[TBL] [Abstract][Full Text] [Related]
12. Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation.
Beales IL; Ogunwobi OO
J Mol Endocrinol; 2009 Apr; 42(4):305-18. PubMed ID: 19153190
[TBL] [Abstract][Full Text] [Related]
13. Identification of progastrin derived peptides in colorectal carcinoma extracts.
Nemeth J; Taylor B; Pauwels S; Varro A; Dockray GJ
Gut; 1993 Jan; 34(1):90-5. PubMed ID: 8432459
[TBL] [Abstract][Full Text] [Related]
14. Role of Annexin-II in GI cancers: interaction with gastrins/progastrins.
Singh P
Cancer Lett; 2007 Jul; 252(1):19-35. PubMed ID: 17188424
[TBL] [Abstract][Full Text] [Related]
15. Expression of the C-terminal flanking peptide of human progastrin in human gastroduodenal mucosa, G-cell hyperplasia and islet cell tumours producing gastrin.
Hara M; Varndell IM; Bishop AE; Aitchison M; Rode J; Yamada T; Green DM; Bloom SR; Polak JM
Mol Cell Probes; 1987 Mar; 1(1):95-108. PubMed ID: 2840576
[TBL] [Abstract][Full Text] [Related]
16. Identification of gastrin component I as gastrin-71. The largest possible bioactive progastrin product.
Rehfeld JF; Johnsen AH
Eur J Biochem; 1994 Aug; 223(3):765-73. PubMed ID: 8055952
[TBL] [Abstract][Full Text] [Related]
17. Processing of the gastrin precursor. Modulation of phosphorylated, sulfated, and amidated products.
Varro A; Nemeth J; Bridson J; Lee C; Moore S; Dockray GJ
J Biol Chem; 1990 Dec; 265(35):21476-81. PubMed ID: 1701434
[TBL] [Abstract][Full Text] [Related]
18. Biologically active recombinant human progastrin(6-80) contains a tightly bound calcium ion.
Baldwin GS; Hollande F; Yang Z; Karelina Y; Paterson A; Strang R; Fourmy D; Neumann G; Shulkes A
J Biol Chem; 2001 Mar; 276(11):7791-6. PubMed ID: 11113148
[TBL] [Abstract][Full Text] [Related]
19. Biology and pathology of non-amidated gastrins.
Shulkes A; Baldwin G
Scand J Clin Lab Invest Suppl; 2001; 234():123-8. PubMed ID: 11713973
[TBL] [Abstract][Full Text] [Related]
20. 13-acetoxysarcocrassolide induces apoptosis on human gastric carcinoma cells through mitochondria-related apoptotic pathways: p38/JNK activation and PI3K/AKT suppression.
Su CC; Chen JY; Din ZH; Su JH; Yang ZY; Chen YJ; Wang RY; Wu YJ
Mar Drugs; 2014 Oct; 12(10):5295-315. PubMed ID: 25342459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
